Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and T... ( While no significant differences were...)

HOME >> MEDICINE >> TECHNOLOGY

Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent

Date:9/4/2007

While no significant differences were found, results showed CYPHER(R) Stent

had lower mortality and heart attack rates

VIENNA, Austria, Sept. 4 /PRNewswire/ -- A subgroup analysis of diabetic patient data from a two-year randomized controlled trial comparing the CYPHER(R) Sirolimus-eluting Coronary Stent to the Taxus Stent showed no statistically significant differences in safety outcomes between the two drug- eluting stents. The authors of the analysis, presented today at the European Society of Cardiology Congress 2007 (ESC Congress 2007), also reported that in the CYPHER(R) Stent arm there were numerically lower rates of cardiac mortality, blood clots and heart attack rates than in the Taxus Stent arm, although these differences did not reach statistical significance.

"In this analysis of head-to-head randomized controlled trial data, both drug-eluting stents yielded similar safety outcomes and the CYPHER(R) Stent presented safety rates in some areas that were numerically lower," Giulio Guagliumi, M.D., from the Ospedale Riuniti Di Bergamo in Bergamo, Italy, who presented the results on behalf of the REALITY Trial investigators.

The cardiac death rates were 1.6 percent for the CYPHER(R) Stent and 4.7 percent for the Taxus Stent (p=0.14). The rate of Q-wave myocardial infarction (heart attacks that involve the full thickness of the heart wall) was 0.0 percent for the CYPHER(R) Stent and 1.6 percent for the Taxus Stent (p=0.25). In addition, the rates of non-Q wave myocardial infarctions (heart attacks that do not involve the full thickness of the heart wall) were 4.8 percent for the CYPHER(R) Stent and 5.2 percent for the Taxus Stent (p=1.00). None of these numerical differences in favor of the CYPHER(R) Stent reached statistical significance.

Both drug-eluting stents were also equivalent in terms of major adverse cardiac events (MACE), which in this study were defined to include cardiac deaths, Q-wave myocardial infa
'/>"/>

SOURCE Cordis Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
2. Two-year data for Angiotechs Vascular Wrap Paclitaxel-Eluting Mesh to be Presented at European Vascular Symposium
3. Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stents Positive Clinical Profile
4. Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in Real World Uses
5. Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
6. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
7. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
8. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
9. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
10. Urinalysis Analyzers: Large Capabilities in Every Size Device
11. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology

Post Your Comments:

(Date:6/17/2013)... WASHINGTON , June 17, 2013 ... ) presented additional data today at ENDO 2013, ... demonstrating that tasimelteon can entrain (synchronize) both melatonin ... potential to reset the master body clock and ... Non-24-Hour Disorder (Non-24). The SET (Safety and Efficacy ...

(Date:6/17/2013)... 17, 2013 DNAtrix Inc., experts in oncolytic ... clinical data on the company,s lead product, DNX-2401, at ... Quebec City, Canada on June 18, 2013. ... and a leader in the field of oncolytic virus ... A PHASE I TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS ...

(Date:6/17/2013)... BioMed Realty Trust, Inc. (NYSE: BMR ... a second quarter 2013 dividend of $0.235 per share of ... of $0.94 per common share. The common ... of record at the close of business on June 28, ... BioMed Realty delivers optimal real estate solutions for biotechnology and ...

Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4 DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2 BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2 BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3

[0] Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder [0] DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus [0] BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend

... market research report is available in its catalogue: , , , ... , , ... Reports details , , , ... high, growing demand worldwide? , , , ...

... Cochlear, the global leader in implantable hearing ... Clark Cochlear Scholarship. Presented by Cochlear Americas, the Graeme ... seniors who,ve demonstrated exceptional achievements both in the classroom ... implant and will receive financial assistance toward their chosen ...

Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 Cochlear Americas Honors Achievements of Cochlear Implant Recipients during May's Better Hearing & Speech Month

(Date:6/18/2013)... Wilkes-Barre, Pennsylvania (PRWEB) June 18, 2013 Sun ... Maternal and Family Health Services 20th Annual Golf Tournament on ... , The hole-in-one prize is a 2013 Buick Verano ... Tournament who gets a hole-in-one on Irem’s 7th hole. , ... The tournament format is a four person captain and crew ...

(Date:6/18/2013)... researchers have launched an innovative clinical trial, unique ... of a patient,s own stem cells to prevent ... (PAD). , Led by Vik Kashyap, MD, ... Medical Center,s Harrington Heart & Vascular Institute and ... School of Medicine, the clinical trial is designed ...

(Date:6/18/2013)... Los Angeles, CA (PRWEB) June 18, 2013 ... article entitled “The Cheater’s Guide to Getting Beach Ready,” offers ... women ready to look their best in a bathing suit ... marks , skin firming , smoothing cellulite , ... says Dr. Simon Ourian, Medical Director of Epione Beverly Hills, ...

(Date:6/18/2013)... 2013 Healthcare Solutions , ... Procura Management, today announced the appointment of Richard ... In this position, Leonardo will direct Healthcare Solutions’ ... strategic growth initiatives. , Recognized in the property ... Leonardo brings more than 20 years of experience ...

(Date:6/18/2013)... Calif. (PRWEB) June 18, 2013 David ... professor of Family Medicine for the College of Osteopathic ... Health Sciences has been elected president of the ... Edmund G. Brown Jr. appointed Connett, a 1984 alumnus ... OMBC members recently elected Connett to the position during ...

Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2 Health News:Skin Care – Getting Your Body Beach Ready 2 Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2

[0] Sun Buick GMC Sponsors Hole-In-One Contest For Maternal and Family Health Services Golf Tournament [0] UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation [0] Skin Care – Getting Your Body Beach Ready [0] Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer [0] WesternU's David Connett Elected OMBC President

... March 5 The California Veterinary Medical Association ... at risk when procedures such as teeth cleaning ... individuals. This is because special training is necessary ... special instruments and may require anesthesia. Under California ...

... patients might get, experts warn , , THURSDAY, March 5 ... to be dietitians have positive or neutral attitudes toward ... biased against their prospective patients, a new study has ... not immune to weight bias, and there are negative ...

... Europe and Asia to Realize New Executive LeadershipKOBE, ... Stock Exchange), a leading medical diagnostics instrument ... executive leadership changes at Sysmex Corporate and its ... Effective April 1, 2009, Kazuya Obe will return ...

... lethal viruses that have emerged in recent outbreaks are susceptible ... malaria, according to a new basic science study by researchers ... Virology . Due to the study,s significance, it was published ... , The two henipaviruses that are the subject of the ...

... 5 LifeSynch, a health and productivity improvement ... Norfolk Southern Corp. ( http://www.nscorp.com ) to provide ... fitness and health coaching services for the organization,s ... WellNS, Norfolk Southern provides an innovative support and ...

... to fighting zoonotic diseases like avian influenza and West ... has received a $100,000 grant from the Rockefeller Foundation.It,s ... zoonotic, meaning that they are transferred from animals to ... Health concept is dedicated to tackling new and existing ...

Cached Medicine News:Health News:Consumers Beware: Unlicensed Care of Animals May Cause Health Problems and Increased Costs 2 Health News:Bias Against Obesity Is Found Among Future Dietitians 2 Health News:Bias Against Obesity Is Found Among Future Dietitians 3 Health News:Sysmex Corporation Announces Organizational Changes 2 Health News:Drug blocks 2 of world's deadliest emerging viruses 2 Health News:Drug blocks 2 of world's deadliest emerging viruses 3 Health News:LifeSynch Chosen to Provide Wellness Services to Norfolk Southern 2 Health News:Rockefeller Foundation Bestows Grant to Fund National One Health Commission 2 Health News:Rockefeller Foundation Bestows Grant to Fund National One Health Commission 3

Consumers Beware: Unlicensed Care of Animals May Cause Health Problems and Increased Costs Bias Against Obesity Is Found Among Future Dietitians Sysmex Corporation Announces Organizational Changes Drug blocks 2 of world's deadliest emerging viruses LifeSynch Chosen to Provide Wellness Services to Norfolk Southern Rockefeller Foundation Bestows Grant to Fund National One Health Commission

Cannulated Interference Screws...

... excellent protection and ease of use. It ... to an adhesive in molecular weight than ... maintain viscosity at high shear rates, giving ... superb performance during capsulorhexis, phaco, IOL insertion, ...

Finally, a camera that sees the way you do!,Combined with the MicroLux DVR (Digital Video Recorder), the MicroLux Headlight Camera System gives you an entirely new way to visualize, edit, share and...

... Optional supine measurement position is achieved ... gantry and a non-magnetic, mobile patient bed. ... outside the shielded room. In case of ... rapidly outside the shielded room for e.g. ...

Medicine Products:

PHANTOM Absorbable Cannulated Interference Screws CoEase (1.2% sodium hyaluronate) viscoelastic solution The MicroLux Headlight Camera System Neuromag-122